Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Cisplatin/5-FU and Adjuvant IP Floxuridine in Gastric Cancer
NCT00002783Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- May 1996
- Primary completion
- Jan 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cisplatin, fluorouracil, floxuridine in gastric cancer (GC), sponsored by Memorial Sloan Kettering Cancer Center. Started May 1996; status: completed.
02
Drugs
cisplatinfluorouracilfloxuridine
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT00002783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002783.